Recent PFE News
- Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/03/2023 09:30:55 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 01/31/2023 01:12:29 PM
- PFIZER REPORTS RECORD FULL-YEAR 2022 RESULTS AND PROVIDES FULL-YEAR 2023 FINANCIAL GUIDANCE • Business Wire • 01/31/2023 11:45:00 AM
- EU Might Buy Fewer Vaccine Doses From Pfizer, BioNTech for Higher Price, Reuters Reports • Dow Jones News • 01/27/2023 01:50:00 PM
- When Does Pfizer Become A Bargain? • ValueWalk • 01/24/2023 11:04:42 PM
- Pfizer Expands ‘An Accord for a Healthier World’ Product Offering to Include Full Portfolio for Greater Benefit to 1.2 Billion People in 45 Lower-Income Countries • Business Wire • 01/17/2023 11:45:00 AM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/13/2023 11:40:51 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/13/2023 11:40:38 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/13/2023 11:40:34 PM
- Pfizer Gets FDA Priority Review of Prevnar 20 for Kids • Dow Jones News • 01/06/2023 12:26:00 PM
- U.S. FDA Accepts for Priority Review the Supplemental Biologics License Application for Pfizer’s 20-Valent Pneumococcal Conjugate Vaccine in Infants and Children • Business Wire • 01/06/2023 11:45:00 AM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/03/2023 11:53:23 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/03/2023 11:53:10 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/03/2023 11:53:07 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/03/2023 11:53:04 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/03/2023 10:51:19 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/03/2023 10:51:06 PM
- Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference • Business Wire • 01/03/2023 03:00:00 PM
- China Approves Merck's Molnupiravir for Emergency Use, Regulator Says -- Update • Dow Jones News • 12/30/2022 12:33:00 PM
- Pfizer's Hemophilia Therapy Study Meets Key Targets • Dow Jones News • 12/29/2022 12:55:00 PM
- Pfizer Announces Positive Top-Line Results from Phase 3 Study of Hemophilia B Gene Therapy Candidate • Business Wire • 12/29/2022 11:45:00 AM
- Pfizer Says FDA to Review Meningococcal Vaccine Application • Dow Jones News • 12/28/2022 12:50:00 PM
- U.S. FDA Accepts for Review the Biologics License Application for Pfizer’s Investigational Pentavalent Meningococcal Vaccine Candidate (MenABCWY) in Adolescents • Business Wire • 12/28/2022 11:45:00 AM
- Oric Pharmaceuticals Shares Soar on Pfizer's $25 Million Investment • Dow Jones News • 12/22/2022 12:40:00 PM
- U.S., EU Regulators to Review Pfizer's Ulcerative Colitis Treatment • Dow Jones News • 12/21/2022 12:40:00 PM
FEATURED American Green (OTC:ERBB) Signs $12 Million Dollar Non-Binding Letter of Intent for Funding of its Cypress Chill Cannabis Grow Facility PHOENIX, AZ (January 7, • Feb 7, 2023 9:17 AM
FEATURED Goldshore Intersects 9.46 g/t Au over 7.45m in the Southwest Zone • Feb 7, 2023 7:00 AM
Chairman & CEO Joshua Sodaitis Announces Annual Letter to Shareholders • PTOP • Feb 7, 2023 10:00 AM
American Green (OTC:ERBB) Signs $12 Million Dollar Non-Binding Letter of Intent for Funding of its Cypress Chill Cannabis Grow • ERBB • Feb 7, 2023 9:17 AM
Good Gaming Inc. To Launch Its First Extreme Game Mob Wars For Advanced Players As Minecraft and Roblox Continue To Experience Rapid Growth • GMER • Feb 7, 2023 8:30 AM
B2Digital's B2 Fighting Series Kicks Off 2023 with New Single-Event Company Record at B2FS 178 • BTDG • Feb 7, 2023 8:30 AM